The FDA’s rule change requires that all women in the US be informed about breast density and options for supplemental screening.
Academic rigour, journalistic flair
Articles on Breast cancer screening
Displaying 1 - 20 of 22 articles
Women may be classed as high or low risk, and screened differently. But the path forward is not clear cut.
Early detection is crucial in the fight against breast cancer. Yet the Canadian Task Force on Preventive Health Care’s new guidelines do not endorse breast cancer screening for women in their 40s.
Olivia Munn recently shared on Instagram that she’d had a double mastectomy after being diagnosed with luminal B breast cancer.
Dense breast tissue is common and normal, but it can make cancer more difficult to detect. FDA requirements going into effect in September 2024 will dictate that patients be better informed about it.
Early detection of breast cancer is critical to improving chances of survival. But racial and ethnic minority patients systematically have delayed diagnoses that reduce the benefits of screening.
As Australian women over 50 prepare to have their COVID shot, they need to factor in timing of their mammogram. Here’s why.
New research estimates 24% of cancers in men that were detected in 2012 were overdiagnosed, meaning they never would have caused harm if left untreated.
Headlines that 70% of women with breast cancer don’t need chemo need to be heeded with caution: it’s a very specific (but substantial) subtype that was studied.
Unfortunately, there is no net benefit-ometer for breast cancer screening.
October is breast cancer awareness month. Women should know there is no reliable evidence that routine mammograms reduce death from breast cancer, and there’s good evidence that they cause harm.
Calls to routinely offer breast cancer screening to more women might sound like a good idea, but can harm. Here are three questions to ask when figuring out whether more screening really is better.
Women are told it’s important to self-check their breasts. But is this true?
Women with dense breasts are more likely to develop breast cancer. Density also makes it harder for doctors to detect breast cancer on a mammogram.
Screening may save lives but it comes with a cost - and sometimes unbearable decisions - that shouldn’t be underestimated.
Long gone are the days when breast cancer was seen as a tumour with an underlying relationship with oestrogen. The picture is much more complex.
Researchers have been talking about the dangers of overdiagnosis for some time. But now a national survey shows most people aren’t told about the risk it poses to their health – and they want to know.
Major causes have been identified for most common cancers, like liver and lung. But we still haven’t identified one for breast cancer.
“It might do me some good and it won’t hurt to give it a go.” How often have you heard a phrase like this? Most people have naïve optimism about medical care. That’s the finding of a systematic review…
We’ve known for some time that women with dense breasts are at higher risk of breast cancers that are difficult to detect by mammography. To address this problem, 19 US states have introduced laws requiring…
Top contributors
-
Professor of Public Health, University of Sydney
-
NHMRC Australia Fellow, The University of Melbourne
-
Professor of Breast Cancer Research, Institute of Health and Biomedical Innovation and School of Biomedical Sciences,, Queensland University of Technology
-
Professor of Clinical Epidemiology, Sydney School of Public Health, University of Sydney
-
Professor of Public Health, Bond University
-
Professor of Biostatistics and Cancer Epidemiology, Queen Mary University of London
-
Brett Montgomery is a Friend of The Conversation.
Senior Lecturer in General Practice, The University of Western Australia
-
Senior Research Fellow at Peter MacCallum Cancer Centre; Adjunct Lecturer, Monash University
-
Professor of Cancer Screening, Queen Mary University of London
-
Senior Lecturer in Philosophy of Public Health, University of Cambridge
-
PhD, Brunel University of London
-
Assistant Professor, Bond University
-
Senior Research Fellow, Centre for Genetic Origins of Health and Disease, The University of Western Australia
-
Associate Professor, University of Adelaide
-
Associate professor, University of Sydney
